Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Direct Outreach to Expand Access to Naloxone in the Context of Standing Orders

NCT03241771 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT03241771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03241771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Direct Outreach to Expand Access to Naloxone in the Context of Standing Orders
Lead sponsor
Kaiser Permanente
Phase
Not applicable
Overall status
Completed
Start date
August 14, 2017
Completion date
August 31, 2022
Enrollment
325 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid abuse, overdose, risk behavior